MediPharm Labs Announces Closing of $75 Million Bought Deal Financing

TORONTO, June 17, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce that it has closed its previously announced bought deal offering of 13,514,000 common shares in the capital of the Company […]